Issues Relating to the Release of Proprietary Information and Data for Use in the Validation of Alternative Methods
暂无分享,去创建一个
M Todd | B Garthoff | W Bernhardt | G Bodé | S Farr | R Kolar | C Lumley | M Pieters | V Rogiers | U Sauer | H Spielmann | J Straus | L Warngard | H. Spielmann | G. Bode | J. Straus | B. Garthoff | C. Lumley | R. Kolar | Martin Todd | Wilfried Bernhardt | Spencer Farr | Moniek Pieters | Vera Rogiers | U. Sauer | Lars Warngard
[1] W Slob,et al. Conversion factors estimating indicative chronic no-observed-adverse-effect levels from short-term toxicity data. , 1996, Regulatory toxicology and pharmacology : RTP.
[2] A M Goldberg,et al. The Three Rs: The Way Forward , 1995, Alternatives to laboratory animals : ATLA.
[3] J. P. Van Oosterhout,et al. The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe. , 1997, Regulatory toxicology and pharmacology : RTP.
[4] Horst Spielmann,et al. Alternatives to the Animal Testing of Medical Devices , 1996 .
[5] S. Walker,et al. The value of chronic animal toxicology studies of pharmaceutical compounds: A retrospective analysis. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[6] U. Sauer,et al. Current Status and Future Developments of Databases on Alternative Methods , 1997 .
[7] Michael Balls,et al. The three Rs: the way forward: the report and recommendations of ECVAM Workshop 11. , 1995, Alternatives to laboratory animals : ATLA.
[8] W. Russell,et al. The Three Rs: The Way Forward , 1995 .
[9] J B Houston,et al. Pharmacokinetics in Early Drug Research , 1997, Alternatives to laboratory animals : ATLA.
[10] Alessandro Giuliani,et al. The Integrated Use of Alternative Approaches for Predicting Toxic Hazard , 1995 .
[11] P. H. Bach,et al. The Use of Tissue Slices for Pharmacotoxicology Studies , 1996 .
[12] S. Walker,et al. An International Appraisal of the Minimum Duration of Chronic Animal Toxicity Studies , 1992, Human & experimental toxicology.
[13] M. Pieters,et al. A No-Observed-Adverse-Effect Level of 1000 Mg/Kg in A 28-Day Repeated-Dose Study as a Limit Value for Acute Toxicity Testing , 1998 .